Single-cell transcriptomic analysis uncovers intratumoral heterogeneity and drug-tolerant persister in ALK-rearranged lung adenocarcinoma

Cancer Commun (Lond). 2023 Aug;43(8):951-955. doi: 10.1002/cac2.12449. Epub 2023 Jun 4.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adenocarcinoma of Lung* / drug therapy
  • Adenocarcinoma of Lung* / genetics
  • Humans
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / genetics
  • Lung Neoplasms* / pathology
  • Receptor Protein-Tyrosine Kinases
  • Transcriptome

Substances

  • Receptor Protein-Tyrosine Kinases